SPONSORED BY Health care providers enrolled in 340B report being unable to buy Sanofi drugs for their own outpatient pharmacies at 340B prices, despite Sanofi’s assurances that its rollback on 340B pricing for entities’ contract pharmacies wouldn’t affect 340B pricing …
Category: Federal
The national association of HIV/AIDS clinics and two of its members late last night sued U.S. Health and Human Services (HHS) Secretary Alex Azar in federal court to compel him to protect their rights to buy covered outpatient drugs from …
340B program changes “are needed and long overdue,” U.S. Rep. Greg Walden (R-Ore.), left, and U.S. Sen. Lamar Alexander (R-Tenn.) said today. The two veteran Republican lawmakers, both retiring after this term, invited 340B stakeholders to submit ideas on how …
“Denying outpatient access to appropriate 340B drug pricing is a clear violation of federal law,” Connecticut Attorney General William Tong warned five drug manufacturers today about their restrictions on 340B pricing on drugs dispensed by contract pharmacies.
SPONSORED BY AstraZeneca and Sanofi today made major moves to minimize their exposure to 340B discounts on drugs dispensed by contract pharmacies. Novartis originally planned to do the same today but did not. AstraZeneca and Sanofi Block Access to 340B …
SPONSORED BY A message from 340B Report Publisher and CEO Ted Slafsky: We are pleased to have a sponsored content piece today by Equiscript CEO Michael Burkhold. I encourage you to read it. We will have more information about 340B …
SPONSORED BY Only 30 Providers Are Supplying Merck with Requested 340B Claims Data Only 30—less than 1 percent—of the 340B covered entities that drug manufacturer Merck wrote to this summer seeking their contract pharmacy claims data are sharing their data …
SPONSORED BY Novartis Says It’s Weighing Whether to Start Cutting Off 340B Contract Pharmacy Discounts on Oct. 1. Sanofi Says it Will. (Update 1, Friday Sept. 25, 1:00 p.m. EDT—Merck is “considering any next steps in our effort to ensure …
SPONSORED BY Note from 340B Report Publisher and CEO Ted Slafsky: I look forward to moderating a panel on the latest 340B developments, President Trump’s drug pricing executive orders, as well as the upcoming elections this Tuesday, Sept. 29 at …
SPONSORED BY HHS Top Lawyer Tells Lilly, Don’t Assume We Endorse Your 340B Policy The top lawyer at the U.S. Health and Human Services (HHS) department told drug manufacturer Eli Lilly and Co. in a letter dated Sept. 21 and …
×
*Sign up for news summaries and alerts from 340B Report